Financial results - DOPHARMA INVEST S.R.L.

Financial Summary - Dopharma Invest S.r.l.
Unique identification code: 22279985
Registration number: J35/3079/2007
Nace: 6810
Sales - Ron
-
Net Profit - Ron
-3.605
Employee
The most important financial indicators for the company Dopharma Invest S.r.l. - Unique Identification Number 22279985: sales in 2023 was - euro, registering a net profit of -3.605 euro and having an average number of employees. Firma isi desfasoara activitatea in domeniul Cumpararea si vanzarea de bunuri imobiliare proprii having the NACE code 6810.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Dopharma Invest S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 0 0 0 0 0 0 0 0 - 0
Total Income - EUR 15.805 17.240 9.414 733 4 1.418 0 0 - 136
Total Expenses - EUR 15.865 22.960 12.211 15.307 898 13.396 428 23.443 - 3.741
Gross Profit/Loss - EUR -60 -5.720 -2.797 -14.575 -894 -11.978 -428 -23.443 - -3.605
Net Profit/Loss - EUR -70 -5.720 -2.797 -14.575 -894 -11.978 -428 -23.443 - -3.605
Employees 0 0 0 0 0 0 0 0 - 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.

Check the financial reports for the company - Dopharma Invest S.r.l.

Rating financiar

Financial Rating -
Dopharma Invest S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Dopharma Invest S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Dopharma Invest S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Dopharma Invest S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Dopharma Invest S.r.l. - CUI 22279985

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 424.685 428.229 423.862 416.690 409.043 401.121 393.517 384.790 - 384.814
Current Assets 21.169 21.100 20.325 20.335 19.587 17.795 17.030 16.108 - 16.815
Inventories 0 0 0 0 0 0 0 0 - 0
Receivables 3.604 3.636 3.600 3.540 3.476 3.410 3.346 3.274 - 3.278
Cash 17.565 17.464 16.725 16.795 16.111 14.386 13.684 12.835 - 13.536
Shareholders Funds -130.205 -137.012 -138.411 -150.644 -148.773 -157.870 -155.305 -175.304 - -177.738
Social Capital 7.088 7.147 7.074 6.955 6.827 6.695 6.568 6.422 - 6.423
Debts 576.059 586.341 582.598 587.668 577.402 576.787 565.852 576.202 - 579.366
Income in Advance 0 0 0 0 0 0 0 0 - 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "6810 - 6810"
CAEN Financial Year 6810
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 16.815 euro in 2023 which includes Inventories of 0 euro, Receivables of 3.278 euro and cash availability of 13.536 euro.
The company's Equity was valued at -177.738 euro, while total Liabilities amounted to 579.366 euro. Equity decreased by -2.423 euro, from -175.304 euro in 2021, to -177.738 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Dopharma Invest S.r.l.

Comments - Dopharma Invest S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.